Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia
- PMID: 14985375
- PMCID: PMC1735695
- DOI: 10.1136/jmg.2003.012153
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia
Abstract
Primary erythermalgia is a rare autosomal dominant disease characterised by intermittent burning pain with redness and heat in the extremities. A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified. We performed linkage analysis in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient. Linkage analysis yielded a maximum lod score of 2.11 for both markers D2S2370 and D2S2330. Based on critical recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345. We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C). Our data suggest that mutations in SCN9A cause primary erythermalgia. SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurones, may play an important role in nociception and vasomotor regulation.
Similar articles
-
SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.J Invest Dermatol. 2005 Jun;124(6):1333-8. doi: 10.1111/j.0022-202X.2005.23737.x. J Invest Dermatol. 2005. PMID: 15955112
-
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.Clin Exp Dermatol. 2009 Dec;34(8):e640-2. doi: 10.1111/j.1365-2230.2009.03355.x. Epub 2009 Jun 22. Clin Exp Dermatol. 2009. PMID: 19549232
-
Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A.Arch Dermatol. 2008 Mar;144(3):320-4. doi: 10.1001/archderm.144.3.320. Arch Dermatol. 2008. PMID: 18347287
-
[From gene to disease; primary erythermalgia--a neuropathic disease as a consequence of mutations in a sodium pump gene].Ned Tijdschr Geneeskd. 2006 Jan 28;150(4):194-6. Ned Tijdschr Geneeskd. 2006. PMID: 16471234 Review. Dutch.
-
Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation.Vasc Med. 2012 Feb;17(1):44-9. doi: 10.1177/1358863X11422584. Epub 2011 Oct 27. Vasc Med. 2012. PMID: 22033523 Review.
Cited by
-
Regulation of Nav1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia.PLoS One. 2015 Jun 2;10(6):e0128830. doi: 10.1371/journal.pone.0128830. eCollection 2015. PLoS One. 2015. PMID: 26035178 Free PMC article.
-
Erythromelalgia? A clinical study of people who experience red, hot, painful feet in the community.Int J Vasc Med. 2013;2013:864961. doi: 10.1155/2013/864961. Epub 2013 May 15. Int J Vasc Med. 2013. PMID: 23762561 Free PMC article.
-
Linkage between increased nociception and olfaction via a SCN9A haplotype.PLoS One. 2013 Jul 10;8(7):e68654. doi: 10.1371/journal.pone.0068654. Print 2013. PLoS One. 2013. PMID: 23874707 Free PMC article.
-
Acute monophasic erythromelalgia pain in five children diagnosed as small-fiber neuropathy.Eur J Paediatr Neurol. 2020 Sep;28:198-204. doi: 10.1016/j.ejpn.2020.06.004. Epub 2020 Jul 7. Eur J Paediatr Neurol. 2020. PMID: 32723684 Free PMC article.
-
Computational pipeline to probe NaV1.7 gain-of-function variants in neuropathic painful syndromes.Sci Rep. 2020 Oct 21;10(1):17930. doi: 10.1038/s41598-020-74591-y. Sci Rep. 2020. PMID: 33087732 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases